2022
DOI: 10.1016/j.vaccine.2022.01.036
|View full text |Cite
|
Sign up to set email alerts
|

Estimating the cost of COVID-19 vaccine deployment and introduction in Ghana using the CVIC tool

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
14
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 12 publications
(14 citation statements)
references
References 39 publications
0
14
0
Order By: Relevance
“…We found that the unit cost of delivering mRNA vaccines to be substantially higher than that of viral vector vaccines (Table 2). These differences are driven by vaccine purchasing costs (see itemised costs by country, activity, and component in Additional File 1: Methods S7, Additional File 1: Tables S7-8)-for which we used the lowest purchasing price reported in the public domain for each vaccine [55,56]. We extrapolated these vaccine unit costs for other countries (see Additional File 1: Methods S8 [57][58][59][60] for extrapolation methods; this process did not differentiate by country-specific purchasing agreements) and other vaccination programme setups (i.e.…”
Section: Estimating the Vaccine Delivery And Health Service Costsmentioning
confidence: 99%
“…We found that the unit cost of delivering mRNA vaccines to be substantially higher than that of viral vector vaccines (Table 2). These differences are driven by vaccine purchasing costs (see itemised costs by country, activity, and component in Additional File 1: Methods S7, Additional File 1: Tables S7-8)-for which we used the lowest purchasing price reported in the public domain for each vaccine [55,56]. We extrapolated these vaccine unit costs for other countries (see Additional File 1: Methods S8 [57][58][59][60] for extrapolation methods; this process did not differentiate by country-specific purchasing agreements) and other vaccination programme setups (i.e.…”
Section: Estimating the Vaccine Delivery And Health Service Costsmentioning
confidence: 99%
“…Even though COVID-19 vaccination is currently free with all related cost fully absorbed by states, or through donations, the sustainability of this financing approach is being questioned against the backdrop that the pandemic may linger for a while [ 20 22 ]. Many countries in Africa continue to seek donor support from the global north to acquire vaccines for their citizens [ 23 25 ]. Coupled with the limited capacity of LMICs to locally produce COVID-19 vaccines, the costs associated with the purchase, transport and last mile distribution of COVID-19 vaccines further compound predicaments of already fragile health systems [ 25 ].…”
Section: Introductionmentioning
confidence: 99%
“…Many countries in Africa continue to seek donor support from the global north to acquire vaccines for their citizens [ 23 25 ]. Coupled with the limited capacity of LMICs to locally produce COVID-19 vaccines, the costs associated with the purchase, transport and last mile distribution of COVID-19 vaccines further compound predicaments of already fragile health systems [ 25 ].…”
Section: Introductionmentioning
confidence: 99%
“…In Ghana, the government committed to acquiring COVID-19 vaccines on December 20, 2020 [25]. Ghana was the first country to receive COVID-19 vaccines from the COVAX initiative and began its first vaccine roll out on March 1, 2021 [26,27,28] with the AstraZeneca vaccine. Johnson & Johnson (J&J), Moderna, Pfizer, and Sputnik V were the COVID-19 vaccines also approved and administered in Ghana.…”
Section: Covid-19 Vaccination Analysis For Ghanamentioning
confidence: 99%